medigraphic.com
ISSN 1561-2937 (Print)

2020, Number 4

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2020; 26 (4)

Ischemic heart disease in women. Traditional and female-specific risk factors

Peix GA

Language: Spanish
References: 68
Page: 1-9
PDF size: 196.85 Kb.


ABSTRACT

Cardiovascular disease (CVD) is nowadays the first cause of death at worldwide level. But although its prevalence has been reduced in the high income countries during the last decade, it is just the opposite in low-and-middle-income countries. In our country men die mainly from oncologic diseases, but in women CVD is the first cause of death. Differences in traditional and emergent risk factors, in the pathophysiology of the ischemic heart disease (IHD), the atypical clinical picture and, mainly, the lack of awareness of the problem by clinicians and the own female patients, affect the diagnosis and treatment of IHD in women. Similarities and differences between sexes regarding traditional and emergent female-specific cardiovascular risk factors are presented in order to make possible an earlier detection of the disease, as well as an adequate management to improve prognosis.


REFERENCES

  1. Anuario Estadístico de Salud 2018. Ministerio de Salud Pública de Cuba. La Habana, 2019. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/

  2. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–11.

  3. Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012;33:734–44.

  4. Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, et al. Emergence of nonobstructive coronary artery disease: a woman's problem and need for change in definition on angiography. J Am Coll Cardiol 2015;66:1918–33.

  5. Bairey Merz CN, Andersen H, Sprague E, Burns A, Keida M, Walsh MN. Knowledge, attitudes, and beliefs regarding cardiovascular disease in women. J Am Coll Cardiol 2017;70:123–32.

  6. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Consultado: Enero 31, 2020

  7. https://www.who.int/gho/women_and_health/en/. Consultado: Enero 31, 2020.

  8. Institute of Medicine (US) Committee on Women’s Health Research. Women’s Health Research: Progress, Pitfalls, and Promise. Washington, DC: National Academies Press; 2010.

  9. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the AHA. Circulation 2015;131.

  10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.

  11. Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, Christlieb AR. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med. 1991;90:56S-61S.

  12. Aggarwal NR, Patel HN, Mehta LS, Sanghani RM, Lundberg GP, Lewis SP, et al. Sex differences in ischemic heart disease: Advances, obstacles, and next steps. Circ Cardiovasc Qual Outcomes 2018;11:e004437. DOI: 10.1161/CIRCOUTCOMES.117.004437.

  13. Palmer J, Lloyd A, Steele L, Fotheringham J, Teare D, Iqbal J, et al. Differential risk of ST-segment elevation myocardial infarction in male and female smokers. J Am Coll Cardiol 2019;73:3259–66.

  14. Berta L, Frairia R, Fortunati N, Fazzari A, Gaidano G. Smoking effects on the hormonal balance of fertile women. Horm Res 1992;37:45–8.

  15. Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003;46:91–111.

  16. Tamis-Holland JE. Sex and outcomes after percutaneous coronary intervention: a cause for concern for young women and those with ST-segment elevation myocardial infarction? J Am Heart Assoc 2017;6:1–3.

  17. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366–73.

  18. Bittner V. Lipoprotein abnormalities related to women's health. Am J Cardiol 2002; 90:77i–84i.

  19. Kolovou GD, Kolovou V, Kostakou PM, Mavrogeni S. Body mass index, lipid metabolism and estrogens: their impact on coronary heart disease. Curr Med Chem 2014;21:3455–65.

  20. Polotsky HN, Polotsky AJ. Metabolic implications of menopause. Semin Reprod Med 2010;28:426–34.

  21. Mascarenhas-Melo F, Marado D, Palabra F, Coelho Á, Pinto R, Teixeira-Lemos E, et al. Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol 2013;9:12–61.

  22. Vassalle C, Mercuri A, Maffei S. Oxidative status and cardiovascular risk in women: keeping pink at heart. World J Cardiol 2009;1:26–30.

  23. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998;12:587–92.

  24. Mercuro G, Longu G, Zoncu S, Cherchi A. Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. Am Heart J 1999;137:692–7.

  25. Green SM, Key BL, McCabe RE. Cognitive-behavioral, behavioral, and mindfulness-based therapies for menopausal depression: a review. Maturitas 2015;80:37–47.

  26. Möller-Leimkühler AM. Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin Neurosci 2007;9:71–83.

  27. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and nutrition examination survey. Arch Intern Med 2000;160:1261–8.

  28. Lee JJ, Cook-Wiens G, Johnson BD, Braunstein GD, Berga SL, Stanczyk FZ, et al. Age at menarche and risk of cardiovascular disease outcomes: findings from the National Heart Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation. J Am Heart Assoc 2019;8:e012406. DOI: 10.1161/JAHA.119.012406.

  29. Moran LJ, Norman RJ, Teede HJ. Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol Metab 2015;26:136–43.

  30. Legro RS, Kunselman AR, Dodson WC. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165–9.

  31. Maffei S, Guiducci L, Cugusi L, Cadeddu C, Deidda M, Gallina S, et al. Women-specific predictors of cardiovascular disease risk - new paradigms. Int J Cardiol 2019;286:190–7.

  32. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab 2010;95:2038–49.

  33. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000;20:2414–21.

  34. de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 2011;17:495–500.

  35. Sassarini J, Lumsden MA, Critchley HO. Sex hormone replacement in ovarian failure - new treatment concepts. Best Pract Res Clin Endocrinol Metab 2015;29:105–14.

  36. Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: the multi-ethnic study of atherosclerosis (MESA). Menopause 2012;19:1081–7.

  37. Gibson-Helm M, Teede H, Vincent A. Symptoms, health behavior and understanding of menopause therapy in women with premature menopause. Climacteric 2014;17:666–73.

  38. Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019;4:e553-64.

  39. Yoshida T, Takahashi K, Yamatani H, Takata K, Kurachi H. Impact of surgical menopause on lipid and bone metabolism. Climacteric 2011;14:445–52.

  40. Ley SH, Li Y, Tobias DK, Manson JE, Rosner B, Hu FB, et al. Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women. J Am Heart Assoc 2017:2:6–11.

  41. Wenger NK. Recognizing pregnancy-associated cardiovascular risk factors. Am J Cardiol 2014;113:406–9.

  42. Cohen A, Pieper CF, Brown AJ, Bastian LA. Number of children and risk of metabolic syndrome in women. J Women's Health (Larchmt) 2006;15:763–73.

  43. Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007;23:135–40.

  44. Carr DB, Utzschneider KM, Hull RL, Tong J, Wallace TM, Kodama K, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006;29:2078–83.

  45. Goueslard K, Cottenet J, Mariet AS, Giroud M, Cottin Y, Petit JM, et al. Early cardiovascular events in women with a history of gestational diabetes mellitus. Cardiovasc Diabetol 2016;15:15. DOI 10.1186/s12933-016-0338-0

  46. Guzmán-Gutiérrez E, Abarzúa F, Belmar C, Nien JK, Ramírez MA, Arroyo P, et al. Functional link between adenosine and insulin: a hypothesis for fetoplacental vascular endothelial dysfunction in gestational diabetes. Curr Vasc Pharmacol 2011;9:750–62.

  47. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One 2014;9:1–20.

  48. Fraser A, Nelson SM, Macdonald-Wallis C. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon longitudinal study of parents and children. Circulation 2012;125:1367-80.

  49. Stevens, DU, Al-Nasiry, S, Fajta, MM, Bulten, J, van Dijk AP, van der Vlugt, MJ, et al. Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia. Am J Obstet Gynecol 2014;545:1–6.

  50. Staff AC, Johnsen GM, Dechend R, Redman CWG. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 2014;101–102:120–6.

  51. Robbins CL, Hutchings Y, Dietz PM, Kuklina EV, Callaghan WM. History of preterm birth and subsequent cardiovascular disease: a systematic review. Am J Obstet Gynecol 2014;210:285–97.

  52. Kessous R, Shoham-Vardi I, Pariente G. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol 2013;209:368.e1-8.

  53. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG 2006;113:17-42.

  54. Siddiqui N, Hladunewich M. Understanding the link between the placenta and future cardiovascular disease. Trends Cardiovasc Med 2011;21:88–193.

  55. Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation 2011;124:2839–46.

  56. King TF, Bergin DA, Kent EM, et al. Endothelial progenitor cells in mothers of low-birth weight infants: a link between defective placental vascularization and increased cardiovascular risk? J Clin Endocrinol Metab 2013;98:E33–9.

  57. Smith GC, Pell JP, Walsh D. Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study. BMJ 2003;326:423–4.

  58. Kessous R, Shoham-Vardi I, Pariente G, Ruslan S, Holcberg G, Sheiner E. Recurrent pregnancy loss: a risk factor for long-term maternal atherosclerotic morbidity? Am J Obstet Gynecol 2014;211:(414.e1-11).

  59. Young L, Cho L. Unique cardiovascular risk in women. Heart 2019;105:1656-60.

  60. Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000;90:1463–6.

  61. Durante A, Bronzato S. The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations. J Clin Med Res 2015;7:379–84.

  62. Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, de Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887–93.

  63. Goldstein BI, Carnethon MR, Matthews KA, McIntyre RS, Miller GE, Raghuveer G, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2015;132:965–86.

  64. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure–Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014;129:1350–69.

  65. Bucciarelli V, Caterino AL, Bianco F, Caputi CG, Salerni S, Sciomer S, et al. Depression and cardiovascular disease: The deep blue sea of women’s heart. Trends Cardiovasc Med 2020;30:170-6.

  66. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297–305.

  67. Gehi A, Musselman D, Otte C, Royster EB, Ali S, Whooley MA. Depression and platelet activation in outpatients with stable coronary heart disease: findings from the heart and soul study. Psychiatry Res 2010;175:200–4.

  68. Maas A. Maintaining cardiovascular health: An approach specific to women. Maturitas 2019;124:68–71.




2020     |     www.medigraphic.com